BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15694569)

  • 1. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.
    Alsaadi TM; Shatzel A; Marquez AV; Jorgensen J; Farias S
    Seizure; 2005 Mar; 14(2):139-42. PubMed ID: 15694569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
    Verrotti A; Coppola G; Manco R; Ciambra G; Iannetti P; Grosso S; Balestri P; Franzoni E; Chiarelli F
    Seizure; 2007 Apr; 16(3):271-5. PubMed ID: 17204435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam monotherapy for newly diagnosed epilepsy patients.
    Alsaadi TM; Thieman C
    Seizure; 2003 Apr; 12(3):154-6. PubMed ID: 12651080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam as a treatment option in non-convulsive status epilepticus.
    Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
    Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S; Tanaka T
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P; McCarthy M; Doherty CP; Delanty N
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
    Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
    Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
    Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
    Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam monotherapy for adults with localization-related epilepsy.
    Alsaadi TM; Thieman C; Zusman EE
    Epilepsy Behav; 2002 Oct; 3(5):471-474. PubMed ID: 12609270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.